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A B S T R A C T
Radio frequency (RF) catheter ablation of accessory pathways represents an inter-
ventional method in modern cardiology that has become the first-line treatment for pa-
tients with symptomatic WPW-syndrome. The aim of this study was to analyze: (1) the
learning curve for the ablation procedure; (2) procedural parameters and success; and
(3) personal assessment of the treatment by the patients. Learning curve analysis in-
cluded 195 consecutive patients, who underwent ablation between 1991 and 1996. The
follow-up survey included 65 consecutive patients. The analysis of the procedural pa-
rameters showed significant improvement after 100 cases, implying a completion of the
learning curve at this point. Long-term follow-up showed a high success rate for all
pathways (95.4%). All procedure parameters indicated significantly higher degree of
difficulty for right free-wall and septal pathways, with lowest long-term success rate for
right-sided pathways (78.6%). Personal assessment survey showed high acceptance of
the treatment; the procedure was described as a significant improvement of overall qua-
lity-of-life by 92.3% of patients. The results of this study confirm the catheter ablation of
accessory pathways – in particular after completion of the learning curve – as a low-risk
and highly efficient treatment for symptomatic WPW-syndrome, with a high degree of
patient-related acceptance.
Key words: WPW-syndrome, catheter ablation, accessory pathways.
Introduction
Treatment for patients with symptom-
atic supraventricular tachycardia medi-
ated by reentry through an accessory
pathway is based on two modalities: pal-
liative and curative therapy. The first
group includes antiarrhythmic medica-
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tion and implantation of antitachycar-
dia-pacemakers. While the latter option
is virtually obsolete in this group of pa-
tients, the life-long drug therapy carries
the burden of numerous adverse effects
and possible proarrhythmic action. Surgi-
cal interruption of accessory pathways
was used to cure the arrhythmia, albeit
with risks and costs associated with
open-heart surgery. With the introduc-
tion and the subsequent technical advan-
ces in the procedure of radio frequency
(RF) catheter ablation, a new possibility
has emerged for definitive treatment of
reentrant tachycardia in the WPW syn-
drome, which carried low risk and high
efficacy.
The electrocardiographic syndrome of
functional bundle branch block and shor-
tened PR-interval in otherwise healthy
young individuals with paroxysmal ta-
chycardia was first described by Wolff,
Parkinson and White in 19301. Contem-
porary epidemiological data estimate the
incidence of accessory pathway (Kent
bundle) as an anatomical basis for the
disorder at 1.5 to 4/1,000 individuals2,
with approximately one-half experienc-
ing symptoms3; this makes the WPW syn-
drome a common cause of paroxysmal
supraventricular tachycardia.
The majority of accessory pathways
exhibit anterograde, as well as retrogra-
de conduction capability. If an exclusively
retrograde conducting Kent bundle is en-
countered (up to 30%), it is designated as
concealed pathway, with no typical mor-
phology on the surface ECG in sinus
rhythm, i.e. without the delta wave. The
accessory pathway can be located in any
of the regions alongside the tricuspid and
mitral annulus. Although the conduction
properties and location may be suspected
from the surface and/or tachycardia ECG
recording, their definitive characteristics
with respect to electrophysiologic proper-
ties (such as unidirectional retrograde or
anterograde conduction or bidirectional
conduction; refractory period; involve-
ment in the reentry tachycardia) and an-
atomical location (left or right free wall,
anteroseptal, midseptal, posteroseptal)
are determined during an electrophysio-
logical study.
Techniques for catheter ablation of the
His bundle were introduced in 19824,5.
Initially, direct-current shocks were used,
but this energy source has been virtually
replaced by RF energy, which is delivered
from an external generator and produces
small defined tissue lesions of the endo-
cardium. By the beginning of the 1990s,
catheter ablation has become the treat-
ment of first choice for accessory path-
ways, with reported success rate well
above 90% and extremely rare solitary
complications6–8. The procedure involves
intravascular (venous or arterial, depen-
ding on the location of the pathway)
placement of ablation catheter, mostly
through the transfemoral approach, at
the presumed position of the accessory
pathway. The correct placement of the
catheter is guided by intracardiac ECG,
as well as by fluoroscopy. Then, RF en-
ergy is delivered between the catheter tip
and an indifferent electrode pad on the
patient’s back. This produces local heat-
ing up to 60–70 °C, resulting in a coagula-
tion necrosis with a 3–5 mm radius
around the tip, thus interrupting the con-
duction through the pathway.
Patients and Methods
Catheter ablation
Initially, a standard electrophysiologic
study (EPS) was performed in each pa-
tient, with insertion of up to 4 diagnostic
electrodes to different regions of the
heart (typically, right atrium, coronary si-
nus, right and left ventricle). Intracar-
diac mapping allowed determination of
electrophysiological characteristics and
precise anatomic location of the pathway,
as well as induction and analysis of corre-
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sponding reentry tachycardia. After con-
firming the indication for ablation during
the EPS, procedure was performed using
a steerable ablation catheter, maneuver-
ed under x-ray fluoroscopic control in typ-
ical LAO 60° and RAO 30° positions (Fig-
ure 1). Transfemoral venous, retrograde
arterial or, occasionally, transjugular (for
right-sided pathways) approach was
used.
Learning curve
The clinical characteristics of 195 con-
secutive patients included in the analysis
of the learning curve for typical ablation
parameters are shown in Table 1. Four
parameters of the ablation procedure
were analyzed in order to determine the
completion of the learning curve: proce-
dure duration (minutes), fluoroscopy du-
ration (minutes), number of RF-impulses
(n), and total energy delivered (W). For
the purpose of learning curve analysis,
patients were divided into 4 consecutive
groups, each comprising 50 patients, ex-
cept for the last group, which had 45 pa-
tients. Procedural parameters were also
compared for patients who had evidence
of concomitant atrial fibrillation (AF),
and with respect to conduction properties
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Fig. 1. Placement of diagnostic and ablation catheters during ablation of a left free wall accessory
pathway: high right atrium (HRA), right ventricle (RV), coronary sinus (CS), left ventricle (ABL
LV). RAO 30° and LAO 60° fluoroscopic projections.
TABLE 1
CLINICAL DATA FOR 195 PATIENTS (107 MALES, 88 FEMALES, AGED 11–74 YRS. (38.9  15.2 )
INCLUDED IN THE LEARNING CURVE PROCEDURE PARAMETER ANALYSIS
Tachycardia
Since (years) 16.0  13.2 (1 month to 60 years)
Incidence (paroxysms/year) 93.5  154.9 (1/year up to several/day)
Maximal duration (hours) 7.8  12.5 (0–72)
Frequency (bpm) 207.6  39.0 (120–340)
Syncope (N, %) 42 (21.5%)
Resuscitation (N, %) 10 (5.1%)
Antiarrhythmic drugs per patent 1.9  1.6 (0–6)
No medication (N, %) 45 (23.1%)
of the accessory pathway (unidirectional
retrograde, anterograde, or bidirectional).
Follow-up of success rate, recurrence
and personal assessment of the
procedure by the patients
Clinical data for 65 patients included
in the analysis of immediate success, long-
-term success, rate of recurrence of con-
duction through the accessory pathway,
late block after the catheter ablation (de-
layed success) and personal follow-up are
listed in Table 2. Long-term success was
defined clinically as complete absence of
previous symptoms and signs of paroxys-
mal tachycardia, along with the absence
of delta wave in patients with overt pre-
excitation. Recurrence was defined as re-
appearance of the same symptoms and
signs, and was, in each case, documented
by a ECG recording of the recurrent ta-
chycardia. The timing of recurrence was
also recorded. The patients were ques-
tioned – using a standardized question-
naire, telephonically or in written form –
about their personal assessment of the
catheter ablation as a treatment method
for their arrhythmia. Questions were ask-
ed concerning: (1) feasibility of ablation;
(2) recommending the procedure to other
patients with the same problem; (3) de-
scription of the energy delivery; (4) re-
gaining the full overall quality of life after
the intervention; (5) readiness to repeat
the procedure, if necessary.
Statistics
Numerical data are listed as mean
values  standard deviation. The compa-
rison between continuous variables was
performed using a two-tailed t-test for
unmatched variables. A p-value less than




Procedure parameters for the ablation
of all accessory pathways in 195 patients
with a total of 234 procedures are de-
picted in Figure 2. Highly significant re-
duction was documented for all four pro-
cedure parameters in the second group of
patients (51–100), with subsequent pla-
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TABLE 2
CLINICAL DATA FOR 65 PATIENTS (38 MALES, 27 FEMALES, AGED 13–64 YRS. (38.9  13.9))
INCLUDED IN THE FOLLOW-UP ANALYSIS OF SUCCESS RATE, RECURRENCE AND PERSONAL
ASSESSMENT
Tachycardia
Since (years) 17.1  13.9 (1 month to 50 years)
Incidence (paroxysms/year) 133.7  177.8 (1/year up to several/day)
Maximal duration (hours) 8.8  12.5 (several minutes up to 72h)
Frequency (bpm) 214.5  39.2 (140–340)
Syncope (N, %) 17 (26.2%)
Resuscitation (N, %) 4 (6.2%)
Antiarrhythmic drugs per patient 2.3  1.7 (0–5)
No medication (N, %) 8 (12.5%)
ECG (preexcitation)
Delta wave 43 (67.2%)
No delta wave 19 (29.7%)
Intermittent 2 (3.1%)
teau of values after the 100th patient. Pro-
cedures were significantly shorter, with
less radiation exposure, fewer RF-impul-
ses needed for interruption of the acces-
sory pathway and with reduced total en-
ergy delivered per procedure.
Concomitant atrial fibrillation and
conduction properties of the accessory
pathway
The incidence of atrial fibrillation was
81 out of 234 ablation procedures (34.6%).
The comparison between patients with
and without AF showed a trend for shor-
ter procedure duration and fluoroscopy
time, although these differences were not
statistically significant (Table 3).
There were 61 (26. 1%) concealed ac-
cessory pathways, with retrograde only
conduction. The procedure parameter
analysis showed a tendency for longer ab-
lation duration for these patients, how-
ever, without statistical significance (Ta-
ble 4).
Follow-up data: immediate success rate,
long-term success and recurrence
A total of 79 ablations were performed
in 65 consecutive patients included in the
follow-up. The data were obtained for all
patients, with a mean follow-up period of
53.4±18.7 (36–74) months. In-hospital suc-
cess rate was 82.3%. There were 5 (6.3%)
patients with late conduction block (de-
layed success) after 2 to 5 days. None of
the patients with late block had recur-
rence of conduction. The highest success
rate was achieved for left free wall path-
ways (95.8%), followed by septal (80.0%)
and right free wall pathways (52.4%).
Recurrence was observed in 5 patients
(6.3%), 1 to 12 weeks after the procedure.
4 patients had a left free wall and 1 had
right free wall pathway (recurrence rate
of 8.3% and 4.8%, respectively). All pa-
tients with recurrence underwent a suc-
cessful second ablation procedure and re-
mained tachycardia-free.
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Fig. 2. Groups of cosecutive patients (1–50, 51–100, 101–150, 151–199), procedure duration,
fluoroscopy time, number of RF-impulses per procedure and total energy delivered. Note the
significant reduction for all parameters in the second patients' group (51–100).
Long-term success was achieved in 51
(78.5%) patients after the first and only
ablation. This was increased to 62 (95.4%)
after repeated procedures for recurrences
(Table 5).
Follow-up data: personal assessment of
the procedure by the patients
The data from the follow-up question-
naire showed high degree of acceptance
and satisfaction with the treatment mo-
dality of catheter ablation (Table 6). Only
one patient did not find the method feasi-
ble, because of long duration of the proce-
dure. Majority of patients did perceive
the RF-application; there were only 7
who did not feel the impulse delivery. 5
patients did not regain full overall qual-
ity of life, because they were not as much
disturbed by their tachycardia before the
88
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TABLE 4
COMPARISON OF PROCEDURE PARAMETERS ACCORDING TO CONDUCTION PROPERTIES






Anterograde 11 169.5  59.8 35.6  19.8 6.5  5.6 4698.0  3995.6
Bidirectional 162 155.9  90.1 33.6  23.3 9.4  9.0 9305.7  10392.5
Retrograde 61 175.6  78.8 32.3  20.2 7.3  6.2 6887.5  6528.3
Significance ns ns ns ns ns
TABLE 3
COMPARISON OF PROCEDURE PARAMETERS FOR PATIENTS WITH AND WITHOUT






Yes 81 165.8  83.4 34.8  23.2 8.6  7.7 7805.6  8843.1
No 153 159.5  87.9 32,5  21.8 8.8  8.5 8796.6  9652.8
Significance ns ns ns ns ns
TABLE 5
PARAMETERS OF SUCCESS (LONG-TERM SUCCESS AFTER FIRST ABLATION, TOTAL LONG-TERM






65 51 (78.5%) 62 (95.4%)
According to pathway location
Left free wall 42 36 (85.7%) 42 (100.0%)
Septal 9 8 (88.9%) 9 (100.0%)
Right free wall 14 7 (50.0%) 11 (78.6%)
procedure. Only three patients were not
ready to repeat the ablation procedure, in
case of tachycardia recurrence.
Discussion
The conception of the learning curve is
of significant importance in modern me-
dicine9,10, especially in relation to the in-
troduction of new and complex therapies,
such as catheter ablation, into common
clinical practice. Earlier studies were able
to demonstrate various aspects of the ef-
fect of learning the ablation of accessory
pathways, as well as other supraventri-
cular arrhythmias. One study reported
an increase in primary success rate from
55% for the first 20 patients to 88% for
the next 33 patients11. An analysis of
catheter ablation of accessory pathways
in pediatric patients showed a calculated
90% level of experience after 240 cases12.
An important aspect of completing the
learning curve is the reduction of radia-
tion exposure during fluoroscopy, as sev-
eral studies had documented significant
risks associated with longer duration of
these kind of procedures13,14. The need for
shorter procedures was highlighted by
the fact that a fluoroscopy time exceeding
100 minutes increased the operator risk
for malignancies by 200 times.
The results of our study documented a
significant and constant reduction of all
four relevant physical procedural param-
eters in the second group of consecutive
patients (number 51–100). This implied
the completion of the learning curve after
100 patients. Such results are also in con-
junction with the requirements currently
stated in the ACC/AHA guidelines for
catheter ablation training, which demand
75 procedures during an education period
of 12 months15. The learning effect in-
cludes growing experience with catheter
manipulation and continuous education,
coupled with technical improvements –
such as refinement of regional potential
analysis, new catheters and preformed
introducers.
The 65 consecutive patients with fol-
low-up had baseline clinical and electro-
physiological characteristics, which were
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TABLE 6
PERSONAL ASSESSMENT OF CATHETER ABLATION IN THE PATIENT FOLLOW-UP
Question Answer N (%)
1. Do you find the procedure feasible / acceptable? Yes: 64 (98.5%)
No: 1 (1.5%)









4. Did the ablation give you back your full quality of life? Yes: 60 (92.3%)
No: 5 (7.7%)




typical for our entire patient population.
Long-term success was achieved in 62
(95.4%) of patients, and varied with the
location of the accessory pathway (100%
for left free wall and septal pathways, vs.
78.6% for right free wall pathways). True
recurrences were documented in 5 (6.3%)
patients, with repeated tachycardia oc-
curring after an interval longer than be-
tween the original paroxysms (1 to 12
weeks post ablation). These figures corre-
spond with data found in the literature,
with reported success rates between 86.1%
and 99%, and recurrence rates of 7.8% to
12.3%16–18. In contrast to some results re-
ported by other authors19, we found that
the late block of conduction, which oc-
curred in 5 of our patients, was not asso-
ciated with recurrence.
The answers from the follow-up ques-
tionnaire on acceptance and personal as-
sessment of the procedure were consis-
tently positive. Vast majority had found
the treatment feasible and would have
recommended it to others. As opposed to
some data from the literature2, majority
of our patients did feel the energy deliv-
ery, although only 15 had described the
moment as painful. The positive effect on
the quality of life – an issue of significant
importance as documented by various
previous articles in a more general con-
text20 – had already been demonstrated
for surgical interruption of accessory
pathways21. This issue is important, be-
cause it involves an invasive procedure
with, albeit very rare, potential complica-
tions, for treatment of elective patients
with generally not life-threatening supra-
ventricular arrhythmias, partially with
low intensity of symptoms22. Our results
showed that almost all patients found
their overall quality of life to be signifi-
cantly better after the catheter ablation.
The main limitation of the latter results
is the fact that this group of patients
treated with catheter ablation had not
been compared with a similar group on
drug therapy only. However, such investi-
gation does not seem likely, in view of the
many significant and documented advan-
tages offered by the ablation as an actual
first-line treatment option.
In conclusion, the results of this study
confirm the catheter ablation of accessory
pathways – in particular after completion
of the learning curve – as a low-risk and
highly efficient treatment for symptom-
atic WPW-syndrome, with a high degree
of patient-related acceptance.
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DUGORO^NI REZULTATI I KRIVULJA U^ENJA KOD
RADIOFREKVENTNE ABLACIJE AKCESORNIH SNOPOVA
S A @ E T A K
Radiofrekventna (RF) kateterska ablacija akcesornih snopova predstavlja interven-
cijsku metodu u modernoj kardiologiji, koja je postala terapija prvog izbora u lije~enju
pacijenata sa simptomatskim WPW sindromom. Cilj ove studije bila je analiza: (1) kri-
vulje u~enja za ablacijski postupak; (2) parametara postupka i uspje{nosti; te (3) oso-
bne procjene metode lije~enja od strane pacijenata. U analizu krivulje u~enja uklju~eno
je 195 konzekutivnih pacijenata, kod kojih je u~injena ablacija izme|u 1991. i 1996.
godine. U anketu pra}enja uklju~eno je 65 konzekutivnih bolesnika. Analiza parame-
tara postupka pokazala je zna~ajan napredak nakon 100 slu~ajeva, {to ukazuje na za-
vr{etak krivulje u~enja u tom trenutku. Dugoro~no pra}enje pokazalo je visoku stopu
uspje{nosti za sve akcesorne snopove (95,4%). Svi parametri postupka ukazuju na vi{i
stupanj te{ko}a kod desnostranih i septalnih snopova, pri ~emu je stopa dugoro~ne
uspje{nosti najni`a kod desnostranih snopova (78,6%). Anketa o osobnoj procjeni
pokazala je visoki stupanj prihva}enosti lije~enja: 92,3% pacijenata opisalo je rezultat
postupka kao zna~ajno pobolj{anje ukupne kvalitete `ivota. Rezultati ove studije po-
tvr|uju da je kateterska ablacija akcesornih snopova – posebno nakon zavr{etka kri-
vulje u~enja – niskorizi~na i vrlo u~inkovita metoda lije~enja simptomatskog WPW sin-
droma, s visokim stupnjem prihva}enosti od strane pacijenata.
